Lupus (SLE): vizsgálatok itt: Kína
163 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 44
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06980597 - 1. fázisNot yet taking people in KínaUCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
- Where
- Changzhou
- Életkor
- 18 év and over
- People
- 18
- Run by
- Changzhou No.2 People's Hospital
See details and how to joinNCT06978738 - Korai 1. fázisNot yet taking people in KínaEarly Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 15
- Run by
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT06970951 - Korai 1. fázisTaking peopleUCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 18
- Run by
- Zhejiang University
See details and how to joinNCT06920433 - Korai 1. fázisTaking peopleAn Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 36
- Run by
- Changhai Hospital
See details and how to joinNCT06010472 - 1. fázisTaking peopleStudy of BCMA/CD70 CAR-T Therapy for Refractory cSLE
- Where
- Hangzhou
- Életkor
- 5 év and over
- People
- 18
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06934447 - 1. fázisNot yet taking people in KínaAn Open-label Study of GB261 in Refractory Seropositive Systemic Lupus Erythematosus
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 19
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06945068 - No phaseTaking peopleAn Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 18
- Run by
- The First Affiliated Hospital of University of Science and Technology of China
See details and how to joinNCT06503224 - No phaseTaking peopleChinese Rheumatism Biobank(CRB)
- Where
- Beijing
- People
- 300
- Run by
- Chinese SLE Treatment And Research Group
See details and how to joinNCT06887517 - 2. fázisTaking peopleBCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 50
- Run by
- Peking University People's Hospital
See details and how to joinNCT06794008 - 3. fázisTaking peopleChimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children
- Where
- Guangzhou
- Életkor
- 6 év to 18 év
- People
- 50
- Run by
- Guangzhou Women and Children's Medical Center
See details and how to joinNCT06904729 - No phaseTaking peopleEquecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 6
- Run by
- Tongji Hospital
See details and how to joinNCT06902844 - 1. fázisTaking peopleCD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06349343 - 2. fázisNot yet taking people in KínaClinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)
- Where
- Beijing, Bengbu, Changchun, Changsha, Chengdu, Guangzhou, Hefei, Jinan, Kunming, Langfang, Lanzhou, Meihekou, Mianyang, Nanchang, Nanjing, Nanning, Pu'er, Puyang, Shanghai, Shaoyang, Shenyang, Shenzhen, Shijiazhuang, Shiyan, Suzhou, Taiyuan, Taizhou, Tianjin, Wenzhou, Wuhan, Xi'an, Xi’an, Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 120
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06859931 - 1/2. fázisTaking peopleA Study of SCTB35 in Patients with Systemic Lupus Erythematosus
- Where
- Beijing, Changchun, Guangzhou, Hangzhou, Jiujiang, Kunming, Linfen, Mianyang, Nanchang, Pingxiang, Taiyuan, Xiamen, Xinxiang
- Életkor
- 18 év to 75 év
- People
- 168
- Run by
- Sinocelltech Ltd.
See details and how to joinNCT06841042 - 2. fázisNot yet taking people in KínaStudy of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 150
- Run by
- Keymed Biosciences Co.Ltd
See details and how to joinNCT06791772 - Korai 1. fázisTaking peopleCD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 9
- Run by
- He Huang
See details and how to joinNCT06785519 - 1/2. fázisTaking peopleA Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 15
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06106893 - 1/2. fázisTaking peopleA Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 15
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06106906 - No phaseTaking peopleValidation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- Monash University
See details and how to joinNCT03138941 - No phaseCsak meghívásosUniversal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 15
- Run by
- Bioray Laboratories
See details and how to joinNCT05859997 - 1. fázisTaking peopleEfficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
- Where
- Hangzhou
- Életkor
- 5 év and over
- People
- 18
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06691152 - No phaseTaking peopleHigh Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)
- Where
- Guangzhou
- Életkor
- 14 év and over
- People
- 5000
- Run by
- First Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT06682507 - 1/2. fázisTaking peopleSequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
- Where
- Beijing
- Életkor
- 21 év to 90 év
- People
- 60
- Run by
- Essen Biotech
See details and how to joinNCT06428188 - 1/2. fázisTaking peopleJY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
- Where
- Kunming
- Életkor
- 14 év to 75 év
- People
- 20
- Run by
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
See details and how to joinNCT06675422